“Project TIGER” is CECOG’s Cross-Border Initiative Anticipating the Tumor Board Future. CECOG is proud and happy to give you a short overview of our “Project TIGER” which is supported by a Pfizer grant (Grant ID 34680627). CECOG has formed a strong network of clinicians coming from various countries of Central and Southeastern Europe aimed at raising awareness on the enormous impact of immune oncology in the treatment of malignancies in the geographic region which unites us.read more Cecog Academy Teaser
The CECOG Academy has held a wonderful „Multidisciplinary Course of Thoracic Malignancies“ in Brdo, Slovenia, on February 23 and 24, 2018. The Course was chaired and presided by Prof. Tanja Cufer, and included a very mixed faculty of important opinion leaders in pathology, radiology, surgery, medical oncology and radiotherapy from the region.The young participants of the course have highly enjoyed the meeting and the interaction with the distinguished international faculty. The CECOG Academy looks forward to welcome you to the next such course in the spring of 2019.Meeting Gallery
Kosovo is a new member of the CECOG family. Prof Zielinski welcomes Dr. Ekrem Hyseni Director of the Oncology Clinic of SHSKUK University.
CECOG is proud to announce the foundation of the CECOG Academy as of July 19, 2017. Under the roof of the newly founded "CECOG Academy“, the abundance of all educational activities hitherto conducted by CECOG will be united.Put the CECOG Academy in your pocket now! learn more
|23 – 24|
CECOG is happy to be a Knowledge Partner of the Aspen Healthcare Forum on „Healthcare as an Investment, from Cost to Social Efficiency“ held in Bucharest on October 24, 2017. This conference involving CECOG President Prof. Christoph Zielinski, CECOG partners and friends Dr. Alexander Eniu from Cluj, Dr. Razvan Popescu from Aarau and highest ranking officials from Romania was opened by the President of the Aspen Institute Romania, Mr. Mircea Geoana (see picture).
CECOG is happy to have produced educational material regarding PD-1 and PD-L1 function and importance for the field of immune oncology. Moreover, teaching slides have been produced referring to the intruiging issue of the blood-brain barrier. All material has been accepted for publication by „ESMO Open - Cancer Horizons“ and can be downloaded from its homepage (esmoopen.bml.com)
With the aim to coordinate clinical trials in oncology according to the standards of Good clinical Practice in the area of Central- and Southeastern Europe, the foundation of CECOG was laid in 1999.
CECOG’s range of activity is not only limited to the conduct of clinical trials but also concentrates on education and the definition of quality standards in regard to the care of patients with malignant diseases.
Univ. Prof. Dr. Christoph Zielinski